Medicinal cannabis for chronic pain: The bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations
Eur J Pain
.
2022 Jul;26(6):1183-1185.
doi: 10.1002/ejp.1946.
Epub 2022 Apr 6.
Authors
Elon Eisenberg
1
,
Bart Morlion
2
,
Silviu Brill
3
,
Winfried Häuser
4
5
Affiliations
1
Institute of Pain Medicine, Rambam Health Care Campus, and Technion - Israel Institute of Technology, Haifa, Israel.
2
Leuven Center for Algology & Pain Management, University Hospitals Leuven, Leuven, KU, Belgium.
3
Institute for Pain Medicine, Sourasky Medical Center, Tel Aviv, Israel.
4
Internal Medicine 1, Klinikum Saarbrücken gGmbH, Saarbrücken, Germany.
5
Department Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany.
PMID:
35363933
PMCID:
PMC9323487
DOI:
10.1002/ejp.1946
No abstract available
MeSH terms
Cannabis*
Chronic Pain* / drug therapy
Humans
Medical Marijuana* / therapeutic use
Qualitative Research
Substances
Medical Marijuana